Aesthetic Surgery Journal · 2007 · 16 citations · 4 references
MedicineSurgeryCosmetic DermatologyDrug DeliveryVascular SurgeryLipid DisordersLipid Management
BACKGROUND: Subcutaneous injection of Lipostabil Endovena (Nattermann & Cie, Köln, Germany) has been used to treat periorbital fat pads, as well as localized fat deposits in the abdomen, neck, arms, and thighs. OBJECIVE: The goal of this article was to identify complications resulting from the use of Lipostabil Endovena for treating fat deposits. METHODS: A prospective study was conducted to identify complications associated with injection lipolysis with Lipostabil Endovena. Patients were surveyed at 48 hours, 2 weeks, and 2 months after the last injection session. RESULTS: The 739 patients surveyed received a total of 2852 vials injected. No general symptoms, such as fever, dizziness, gastrointestinal disturbances, or visual disturbances occurred, although local symptoms, including edema, hematoma, pain, and nodules, were reported. CONCLUSIONS: The lack of any reported general complications after injection lipolysis with Lipostabil Endovena is encouraging. However, larger studies are needed to confirm that the use of Lipostabil Endovena is safe.
4